GHRP-6

GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) that acts as a potent agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R1a). It was one of the first synthetic GHRPs developed and remains one of the strongest GH-releasing compounds available. GHRP-6 is distinguished from more selective GHRPs like Ipamorelin by its robust stimulation of appetite — a property that makes it uniquely valuable for specific research contexts and a confounding variable in others.

GHRP-6 activates the GHS-R1a receptor on pituitary somatotrophs, triggering the phospholipase C-IP3-calcium cascade that releases stored GH vesicles. However, unlike Ipamorelin, GHRP-6 also strongly activates GHS-R1a in the hypothalamic arcuate nucleus, stimulating NPY/AgRP neurons that drive appetite. Additionally, GHRP-6 has mild stimulatory effects on cortisol and prolactin secretion, though these effects are generally considered clinically insignificant at standard research doses. The GH-releasing potency of GHRP-6 is among the highest of any GHRP, with acute administration producing 8-15 fold increases in serum GH levels.

The appetite-stimulating properties of GHRP-6 that some researchers view as a side effect are, in specific contexts, its primary advantage. For researchers investigating hard-gainer phenotypes, post-illness recovery of appetite, cachexia-related muscle wasting, or caloric surplus-dependent anabolic protocols, the combination of potent GH release and appetite drive creates a powerful anabolic environment. Studies have documented significant increases in food intake, nitrogen retention, lean body mass, and IGF-1 levels. The GH response to GHRP-6 is rapid (peak at 15-30 minutes post-injection) and robust, though it does show some degree of desensitization with continuous high-dose use.

GHRP-6 is best suited for researchers investigating bulking and mass-gaining protocols, appetite restoration, and high-output GH stimulation. It is the preferred GHRP for researchers who want maximal anabolic signaling and consider appetite stimulation a feature rather than a bug. Pair with CJC-1295 No DAC for synergistic GH release.

Reconstitute the 10mg vial with 2-5ml bacteriostatic water. Administer via subcutaneous injection, typically 100-300mcg per dose, 2-3 times daily. The strong appetite surge occurs 20-30 minutes post-injection and lasts approximately 30-60 minutes. Inject on an empty stomach — the GH response is blunted by elevated blood glucose and free fatty acids. Half-life is approximately 15-20 minutes. Store at 2-8C after reconstitution. The 10mg vial provides extensive supply at standard research dosing.